Case File №
#VI-2026-0766
Weifang Xingbei International Trade
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | X Unrated | 1 | 7.3 | 7.3 | 7.3 | 25 May 2026 |
| AICAR Oral | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| AICAR | X N/A | 1 | 4.0 | 0.3 | 0.3 | 13 Jun 2025 |
| BAM15 | X N/A | 1 | 4.0 | 1.1 | 1.1 | 28 Mar 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 4.0 | 1.3 | 1.3 | 13 Feb 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 1 | 4.0 | 1.8 | 1.8 | 14 Jan 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 4.0 | 0.4 | 0.4 | 6 May 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| DSIP | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Enclomiphene | X N/A | 1 | 4.0 | 2.6 | 2.6 | 8 Jul 2025 |
| Finasteride | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Flibanserin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | X N/A | 1 | 4.0 | 0.6 | 0.6 | 8 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 4.0 | 0.5 | 0.5 | 25 Apr 2025 |
| Gonadorelin | X N/A | 1 | 4.0 | 2.7 | 2.7 | 9 Jun 2025 |
| HGH Fragment 176-191 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Humanin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| IGF-1 LR3 | X N/A | 1 | 4.0 | 0.5 | 0.5 | 9 Jun 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| Liraglutide | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| MOTS-C | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
| Pancragen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Pinealon | X N/A | 1 | 4.0 | 0.1 | 0.1 | 11 Jun 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| S-23 Raw | X N/A | 1 | 4.0 | 3.1 | 3.1 | 2 Apr 2025 |
| Selank | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Superdrol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Testagen | X N/A | 1 | 4.0 | 0.8 | 0.8 | 6 May 2025 |
| Tirzepatide Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Turinabol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
Exhibit II
Evidence Log
32 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Testagen | 4.0 C | 15mg | 18.7mg | +24.5% | 95.55% | jfewjm | Lab A | Public |
| 24 May 2026 | Turinabol | 5.0 B | 100mg | 85.1mg | -14.9% | 96.11% | 4cz33p | Lab F | Public |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 4.0 C | 15mg | 13.6mg | -9.4% | 99.35% | 27vqki | Lab G | Public |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.8 C | 20mg | 18.3mg | -8.7% | 99.40% | 59m46l | Lab B | Community |
| 23 May 2026 | Humanin | 4.0 C | 50mg | 43.7mg | -12.5% | 96.97% | t82v1e | Lab A | Public |
| 21 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.0 C | 5mg | 5.4mg | +7.4% | 96.24% | 6jcgkc | Lab E | Community |
| 21 May 2026 | Superdrol | 6.2 A | 10mg | 11.3mg | +13.5% | 97.96% | pvh8y2 | Lab F | Community |
| 21 May 2026 | S-23 Raw | 5.9 B | 10g | 12.1g | +20.9% | 99.56% | u1v4ir | Lab C | Community |
| 17 May 2026 | Pancragen | 4.0 C | 20mg | 19.3mg | -3.4% | 97.29% | ttvl14 | Lab B | Public |
| 29 Jan 2026 | AICAR Oral | 5.2 B | 10mg | 12.4mg | +24.2% | 97.13% | hgt810 | Lab G | Public |
| 26 Jan 2026 | Pinealon | 4.9 C | 20mg | 18.2mg | -9.0% | 95.76% | 9n04hr | Lab C | Public |
| 19 Jan 2026 | AICAR | 4.5 C | 5mg | 5.4mg | +8.0% | 95.60% | ammwyr | Lab E | Community |
| 19 Jan 2026 | Liraglutide | 5.3 B | 15mg | 18.3mg | +22.2% | 97.71% | a1d57v | Lab C | Public |
| 9 Jan 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 4.0 C | 100mg/ml | 113.3mg/ml | +13.3% | 95.39% | v9lipr | Lab B | Community |
| 9 Jan 2026 | HGH Fragment 176-191 | 4.5 C | 50mg | 42.8mg | -14.4% | 96.13% | 8oxmog | Lab E | Public |
| 6 Jan 2026 | CJC-1295 With DAC | 4.0 C | 5mg | 5.8mg | +16.6% | 98.45% | 13gfhw | Lab C | Public |
| 29 Dec 2025 | Blend 500 (Tren E/Mast E) | 6.8 A | 300mg/ml | 315.5mg/ml | +5.2% | 99.87% | xmo3f9 | Lab D | Public |
| 29 Dec 2025 | Phenylacetic acid CAS 103-82-2 | 5.4 B | 1g | 1.0g | +4.7% | 98.06% | bkh14p | Lab E | Community |
| 12 Dec 2025 | Blend 300 (TRA/Mast P/Test P) | 4.0 C | 100mg/ml | 91.5mg/ml | -8.5% | 99.69% | y7469z | Lab D | Public |
| 12 Dec 2025 | IGF-1 LR3 | 6.0 A | 2mg | 1.9mg | -7.1% | 96.47% | xji3mk | Lab D | Community |
| 12 Dec 2025 | Selank | 4.8 C | 30mg | 27.2mg | -9.2% | 98.33% | 52lpjt | Lab C | Public |
| 5 Dec 2025 | Tirzepatide Raw | 5.2 B | 500g | 603.1g | +20.6% | 96.69% | 8i7jjb | Lab A | Public |
| 23 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 4.6 C | 10g | 11.5g | +15.0% | 96.65% | 35z9dz | Lab C | Community |
| 17 Nov 2025 | MOTS-C | 5.8 B | 2mg | 1.9mg | -7.1% | 95.48% | 13x7el | Lab E | Community |
| 14 Nov 2025 | Flibanserin | 4.0 C | 25mg | 26.2mg | +4.7% | 98.87% | fjxf0f | Lab F | Public |
| 14 Nov 2025 | Gonadorelin | 5.7 B | 50mg | 50.1mg | +0.2% | 97.07% | un5eor | Lab A | Community |
| 14 Nov 2025 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.1 C | 100mg/ml | 108.8mg/ml | +8.8% | 96.09% | pjoktr | Lab E | Community |
| 17 Oct 2025 | Finasteride | 4.4 C | 10mg | 11.0mg | +9.8% | 96.67% | 2tscge | Lab B | Public |
| 17 Oct 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.4 B | 2mg | 1.8mg | -9.1% | 95.67% | uffgnk | Lab A | Public |
| 3 Oct 2025 | BAM15 | 4.0 C | 100mg | 119.0mg | +19.0% | 96.08% | 12um7d | Lab A | Public |
| 3 Oct 2025 | DSIP | 5.2 B | 30mg | 37.3mg | +24.2% | 96.03% | bdnd9n | Lab D | Public |
| 3 Oct 2025 | Enclomiphene | 5.0 B | 100mg | 96.4mg | -3.6% | 96.91% | f3r6gc | Lab B | Community |